ReWalk Robotics Ltd. Stock News

Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury

Lifeward Ltd. (NASDAQ:LFWD ) Q4 2024 Earnings Conference Call March 7, 2025 8:30 AM ET Company Participants Mike Lawless - CFO Larry Jasinski - CEO Almog Adar - VP, Finance Conference Call Participants Yale Jen - Laidlaw & Company Ben Haynor - Lake Street Capital Markets Swayampakula Ramakanth - H.C.

Record quarterly and annual revenue of $7.5M and $25.7M, respectively Continued strong growth in U.S. pipeline of ReWalk opportunities with over 110 qualified leads in process Strategic s hift t owards p rofitability: 2025 Sustainable Growth Plan f ocuses on growth of c ore p roduct l ines with a s treamlined c ost s tructure and r educed o perating loss MARLBOROUGH, Mass. and YOKNEAM ILLIT, Is...

CorLife to become the exclusive distributor of the ReWalk Personal Exoskeleton for individuals with Workers' Compensation claims

New Agreement Expands Distribution Rights to Lifeward to Include Referral Sales for Home Use Applications New Agreement Expands Distribution Rights to Lifeward to Include Referral Sales for Home Use Applications

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a  global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its fourth quarter and fiscal year-end financial results before the markets open on F...